Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients (CHIEF)
|ClinicalTrials.gov Identifier: NCT01011660|
Recruitment Status : Unknown
Verified August 2012 by Ma Liyuan, Cardiovascular Institute & Fuwai Hospital.
Recruitment status was: Recruiting
First Posted : November 11, 2009
Last Update Posted : August 13, 2012
Chinese Academy of Medical Sciences, Fuwai Hospital
Information provided by (Responsible Party):
Ma Liyuan, Cardiovascular Institute & Fuwai Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||August 2012|
|Estimated Study Completion Date :||December 2012|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Ma L, Wang W, Zhao Y, Zhang Y, Deng Q, Liu M, Sun H, Wang J, Liu L. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study. Am J Cardiovasc Drugs. 2012 Apr 1;12(2):137-42. doi: 10.2165/11598110-000000000-00000.